Volume 12; Issue supp-S1

Main
The Breast
Volume 12; Issue supp-S1

The Breast

Volume 12; Issue supp-S1

1

Opening address

Journal:

Year:

2003

Language:

english

File:

PDF, 57 KB

english, 2003

2

Recommendation for mammographic screening after the dust settles

Journal:

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

3

Prophylactic mastectomy

Journal:

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

4

Molecular mechanisms of hormonal resistance in breast cancer: Cross talk between growth factor and estrogen receptor pathways

Journal:

Year:

2003

Language:

english

File:

PDF, 167 KB

english, 2003

5

New data on endocrine treatments

Nancy E. Davidson

Journal:

Year:

2003

Language:

english

File:

PDF, 192 KB

english, 2003

6

New data on chemotherapy in the adjuvant setting

Martine J. Piccart, Fatima Cardoso

Journal:

Year:

2003

Language:

english

File:

PDF, 192 KB

english, 2003

7

Pharmacological prevention of breast cancer: Quo vadis?

Journal:

Year:

2003

Language:

english

File:

PDF, 192 KB

english, 2003

8

The new TNM classification and alternatives

Journal:

Year:

2003

Language:

english

File:

PDF, 192 KB

english, 2003

9

Histopathology of primary breast cancer 2003

Journal:

Year:

2003

Language:

english

File:

PDF, 377 KB

english, 2003

10

Evaluation of regional lymphnodes: New standards?

Viviana Galimberti

Journal:

Year:

2003

Language:

english

File:

PDF, 189 KB

english, 2003

11

Evaluation of bone marrow: Prediction of outcome and response

Stephan Braun, Florian Vogl, Wolfgang Janni, Christian Marth, Günter Schlimok, Klaus Pantel

Journal:

Year:

2003

Language:

english

File:

PDF, 189 KB

english, 2003

12

Risk factors, treatment options and follow-up

Journal:

Year:

2003

Language:

english

File:

PDF, 189 KB

english, 2003

13

Epidemiology of breast cancer

Journal:

Year:

2003

Language:

english

File:

PDF, 189 KB

english, 2003

14

Nutrition and breast cancer

Journal:

Year:

2003

Language:

english

File:

PDF, 378 KB

english, 2003

15

Breast cancer in the media — Friend or enemy?

Journal:

Year:

2003

Language:

english

File:

PDF, 192 KB

english, 2003

16

The role of women's advocacy groups in breast cancer

Journal:

Year:

2003

Language:

english

File:

PDF, 192 KB

english, 2003

17

Internet-information on breast cancer: An overview

Eugenio Santoro

Journal:

Year:

2003

Language:

english

File:

PDF, 192 KB

english, 2003

18

Implications of genetic information at breast cancer diagnosis

Journal:

Year:

2003

Language:

english

File:

PDF, 375 KB

english, 2003

19

Biological targets in breast cancer therapeutics

Journal:

Year:

2003

Language:

english

File:

PDF, 189 KB

english, 2003

20

Hormone receptors, present and future

Journal:

Year:

2003

Language:

english

File:

PDF, 189 KB

english, 2003

21

Efforts to link biological and clinical breast cancer research

Journal:

Year:

2003

Language:

english

File:

PDF, 189 KB

english, 2003

22

Surgery, staging and radiation therapy for DCIS

Journal:

Year:

2003

Language:

english

File:

PDF, 194 KB

english, 2003

23

Ductal carcinoma in-situ: Mortality rates at five years

Elizabeth B. Claus, Meredith Stowe, Darryl Carter

Journal:

Year:

2003

Language:

english

File:

PDF, 194 KB

english, 2003

24

Ductal carcinoma in situ of the breast: The treatment controversy

Melvin J. Silverstein

Journal:

Year:

2003

Language:

english

File:

PDF, 387 KB

english, 2003

25

DCIS: evidence from radomized trials

J. Bryant, S. Land, C. Allred, S. Paik, J. Dignam, L. Habel, R. Smith, C. Geyer Jr., E. Fisher, B. Fisher, N. Wolmark

Journal:

Year:

2003

Language:

english

File:

PDF, 198 KB

english, 2003

26

The future of surgery in the treatment of breast cancer

Journal:

Year:

2003

Language:

english

File:

PDF, 198 KB

english, 2003

27

Radiotherapy to the conserved breast, chest wall, and regional nodes: Is there a standard?

Journal:

Year:

2003

Language:

english

File:

PDF, 385 KB

english, 2003

28

Intraoperative radiotherapy with electrons (ELIOT) to the breast

R. Orecchia, M. Ciocca, R. Lazzari, C. Garibaldi, A. Luini, M. Intra, G. Gatti, P. Veronesi, U. Veronesi

Journal:

Year:

2003

Language:

english

File:

PDF, 192 KB

english, 2003

29

The MammoSite radiation therapy system

Oscar E. Streeter Jr.

Journal:

Year:

2003

Language:

english

File:

PDF, 192 KB

english, 2003

30

The best use of adjuvant endocrine treatments

Kathleen I. Pritchard

Journal:

Year:

2003

Language:

english

File:

PDF, 393 KB

english, 2003

31

Chemo-endocrine therapy: Any need to combine?

Monica Castiglione-Gertsch

Journal:

Year:

2003

Language:

english

File:

PDF, 206 KB

english, 2003

32

Adjuvant therapy for the very young patients

Journal:

Year:

2003

Language:

english

File:

PDF, 384 KB

english, 2003

33

Pregnancy before and after breast cancer

Henning T. Mouridsen, Niels Kroman

Journal:

Year:

2003

Language:

english

File:

PDF, 182 KB

english, 2003

34

The best use of chemotherapy in the adjuvant setting

Martine J. Piccart, Angelo Di Leo, Fatima Cardoso, Ahmad Awada, Christos Sotiriou

Journal:

Year:

2003

Language:

english

File:

PDF, 182 KB

english, 2003

35

Dose of chemotherapy — Cytotoxicity, duration and responsiveness: Can we improve present therapy results by targeted and tailored therapies?

Journal:

Year:

2003

Language:

english

File:

PDF, 369 KB

english, 2003

36

Preoperative systemic treatment: Prediction of responsiveness

Journal:

Year:

2003

Language:

english

File:

PDF, 192 KB

english, 2003

37

Adjuvant chemo-endocrine therapy for breast cancer: Combined or sequential?

Kathy S. Albain

Journal:

Year:

2003

Language:

english

File:

PDF, 192 KB

english, 2003

38

Markers of increased risk for failure of adjuvant therapies

Daniel F. Hayes

Journal:

Year:

2003

Language:

english

File:

PDF, 195 KB

english, 2003

39

Adjuvant therapy for elderly women

Journal:

Year:

2003

Language:

english

File:

PDF, 289 KB

english, 2003

40

Tailoring treatments for the individual patient

Richard D. Gelber, Marco Bonetti, Aron Goldhirsch

Journal:

Year:

2003

Language:

english

File:

PDF, 99 KB

english, 2003

41

An overview of novel treatments which might enter adjuvant clinical trials in the next future

Journal:

Year:

2003

Language:

english

File:

PDF, 99 KB

english, 2003

42

Cancer familiarity status in patients with early brest cancer: Our experience

T. Latiano, L. Tozz, C. D'Addetta, G. Cilenti, G. Capuano, R. Murgo, M. Bisceglie, S. Parisi, B. Tardio, M. Aieta, V.M. Valori

Journal:

Year:

2003

Language:

english

File:

PDF, 183 KB

english, 2003

43

Population study on brca 12 mutations in women with breast and ovarian cancers in western Sweden

Z. Einbeigi, A. Bergman, P. Karlsson, L-G. Kindblom, T. Martinsson, J. Meis-Kindblom, M. Nordling, J. Wahlström, A. Wallgren

Journal:

Year:

2003

Language:

english

File:

PDF, 183 KB

english, 2003

44

High throughput tissue microarray analysis of cyclooxygenase-2 expression in human breast cancer: Correlation to clinicopathological data and long-term follow-up

P. Wulfing, R. Diallo, C. Muller, C. Wulfing, C. Poremba, R. Greb, W. Bocker, L. Kiesel

Journal:

Year:

2003

Language:

english

File:

PDF, 183 KB

english, 2003

45

A population-based study of the impact of the St-Gallen treatment guidelines on survival of women with node-negative breast cancer

N. Hebert-Croteau, J. Brisson, J. Latreille, M. Rivard, G. Martin, J. Cantin

Journal:

Year:

2003

Language:

english

File:

PDF, 371 KB

english, 2003

46

Survival of breast cancer patients treated in Tripoli/Libya 1990–1999

Manal El-Habbash, Abokris Alwindi, Khalil Ekhabbash

Journal:

Year:

2003

Language:

english

File:

PDF, 193 KB

english, 2003

47

The prognostic influence of body mass index in premenopausal breast cancer patients

S. Taucher, M. Gnant, H. Hausmaninger, E. Kubista, P. Wagner, Th. Payrits, G. Steger, Ch. Tausch, R. Jakesz

Journal:

Year:

2003

Language:

english

File:

PDF, 193 KB

english, 2003

48

Mammographic density and obesity as risk factors for invasive breast cancer following ductal carcinoma in situ (DCIS)

J. Dignam, L. Habel, S. Land, T. Julian, B. Fisher, N. Wolmark

Journal:

Year:

2003

Language:

english

File:

PDF, 193 KB

english, 2003

49

Hapatitis B virus (HBV) reactivation in breast cancer patients undergoing cytotoxic chemotherapy-High HBV DNA viral load is an important risk factor

W. Yeo, Z. Sheng, P.K.S. Chan, B. Zee, W.M. Ho, W.L. Wong, W.H. Kwan, P.J. Johnson

Journal:

Year:

2003

Language:

english

File:

PDF, 209 KB

english, 2003

50

Prospective evaluation of prognostic factors in primary breast cancer, single surgeon series

A.P. Makar, K. Melis, S. Declercq, A. Vervaet, D. Van Den Weyngaert

Journal:

Year:

2003

Language:

english

File:

PDF, 209 KB

english, 2003

51

Relation between preoperative values of CA15-3 and duration of disease-free interval in patients with operabile breast cancer

Journal:

Year:

2003

Language:

english

File:

PDF, 209 KB

english, 2003

52

Breast cancer awareness and screening — Where do we stand? A pilot trial — VN Cancer Centre, Coimbatore, India

G. Govindarajulu, V. Nagarajan, N.R. Tulasi, Ila Chauhan

Journal:

Year:

2003

Language:

english

File:

PDF, 394 KB

english, 2003

53

Baseline radiological staging in early breast cancer: A comparison of practice guideline recommendations with actual clinical practice

M. Clemons, F. Wright, E. McWhirter, G. Dranitsaris, C. Holloway, F. Charbonneau, M. Trudeau, A. Smith, G. Yogendran, A. Mehlenbacher

Journal:

Year:

2003

Language:

english

File:

PDF, 190 KB

english, 2003

54

Multitarget stereotactic breast biopsy — A short and safe diagnostic intervention for non-palpable breast-lesions

E. Senn-Bahls, V. Dupont Lambert, H.J. Senn

Journal:

Year:

2003

Language:

english

File:

PDF, 190 KB

english, 2003

55

The mammotome is a new valid and minimally invasive technology for obtaining multiple breast biopsies in an ambulant setting

H. Van den Bosch, A.P. Makar, D. Becquaert, S. Declercq, A. Esmans, D. Van Den Weyngaert

Journal:

Year:

2003

Language:

english

File:

PDF, 190 KB

english, 2003

56

Persistence of occult metastatic cells in bone marrow of breast cancer patients despite systemic adjuvant treatment

W. Janni, B. Rack, D. Rjosk, E. Klanner, C. Kentenich, C. Schindlbeck, S. Braun, H. Sommer

Journal:

Year:

2003

Language:

english

File:

PDF, 218 KB

english, 2003

57

The process of metastasization for breast cancer

J. Engel, R. Eckel, J. Kerr, M. Schmidt, G. Fuerstanberger, R. Richter, H. Sauer, H.-J. Senn, D. Hoelzel

Journal:

Year:

2003

Language:

english

File:

PDF, 218 KB

english, 2003

58

Calcitonin gene related peptide (CGRP) and calcitonin (CT) immunohistochemistry in relation with the presence of microcalcifications (MC) in invasive and preinvasive breast lesions: Influence in Tc-99m (V)DMSA and Tc-99m MIBI scintimammography (SM)

V. Papantoniou, I. Christodoulidou, M. Souvatzoglou, V. Valotassiou, A. Louvrou, D. Lazaris, M. Melissinou, L. Nakopoulou, Ch. Zerva, S. Michalas

Journal:

Year:

2003

Language:

english

File:

PDF, 218 KB

english, 2003

59

Dolichol as a tumor marker in early breast cancer

S. Kuznecovs, G. Kuznecova

Journal:

Year:

2003

Language:

english

File:

PDF, 412 KB

english, 2003

60

Tumorigenic and prognostic roles of FHIT in early breast cancer

Q. Yang, T. Sakurai, H. Li, G. Yoshimura, T. Suzuma, T. Umemura, M. Nakamura, Y. Nakamura, I. Mori, K. Kakudo

Journal:

Year:

2003

Language:

english

File:

PDF, 198 KB

english, 2003

61

Efforts to link biological and clinical breast cancer research

Journal:

Year:

2003

Language:

english

File:

PDF, 198 KB

english, 2003

62

Level-I evidence for prognostic impact of UPA and PAI-1 in node-negative breast cancer patients: Ready for use in clinical routine

C. Thomssen, N. Harbeck, C. Meisner, A. Prechtl, M. Untch, B. Lisboa, H. Selbmann, M. Schmitt, F. Jaenicke

Journal:

Year:

2003

Language:

english

File:

PDF, 198 KB

english, 2003

63

A trial to improve risk estimation and risk adapted adjuvant chemotherapy in node-negative breast cancer patients: NNBC-3 Europe

V. Mueller, C. Thomssen, N. Harbeck, R. Paridens, F. Herbst, H. Selbmann, C. Meisner, F. Sweep, M. Schmitt, F. Jaenicke

Journal:

Year:

2003

Language:

english

File:

PDF, 392 KB

english, 2003

64

Combination of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) has not only prognostic but also predictive impact in primary breast cancer

N. Harbeck, R. Kates, M. Look, C. Thomssen, F. Jänicke, J.G.M. Klijn, M. Kiechle, M. Schmitt, J. Foekens

Journal:

Year:

2003

Language:

english

File:

PDF, 197 KB

english, 2003

65

Tumour proliferative activity is predictive of 10-year relapse in patients with node-negative, low-risk (tumour size 1 cm or 1–2 cm) breast cancers

M.G. Daidone, S. Veneroni, R. Motta, L. Ventura, G. Tomasic, G. Martelli, D. Coradini

Journal:

Year:

2003

Language:

english

File:

PDF, 197 KB

english, 2003

66

HER2 status and UPA/PAI-1 provide complementary information on patient outcome in node-negative breast cancer

I. Zemzoum, R. Kates, M. Schmitt, J. Ross, H. Höfler, M. Kiechle, N. Harbeck

Journal:

Year:

2003

Language:

english

File:

PDF, 408 KB

english, 2003

67

Cell proliferation (Ki-67) relationship with Tc-99m (V)DMSA uptake in breast cancer. Multivariate regression analysis with other prognostic factors: Comparative study with Tc-99m MIBI

V. Papantoniou, M. Souvatzoglou, V. Valotassiou, I. Christodoulidou, J. Koutsikos, A. Louvrou, M. Melissinou, M. Bebi, L. Nakopoulou, Ch. Zerva

Journal:

Year:

2003

Language:

english

File:

PDF, 217 KB

english, 2003

68

Neoangiogenesis in invasive and preinvasive breast cancer. Relationship with calcitonin gene related peptide (CGRP) immunohistochemistry and mammographically detected microcalcifications (MC). Influence in Tcc-99m (V)DMSA and Tc-99m MIBI tumour uptake

V. Papantoniou, M. Souvatzoglou, I. Christodoulidou, V. Valotassiou, J. Koutsikos, K. Ampela, M. Bebi, M. Sotiropoulou, Ch. Zerva, S. Michalas

Journal:

Year:

2003

Language:

english

File:

PDF, 217 KB

english, 2003

69

HER2 status in advanced breast cancer: which option for aromatase inhibitors?

A. Bertolini, G. Scognamiglio, O. Fusco, G. Andreola, A. Fasolo, A. Ardizzoia, M. Giordano, S. Brugnatelli, V. Filippazzi, A. Scanni

Journal:

Year:

2003

Language:

english

File:

PDF, 217 KB

english, 2003

70

Is nodal involvement still relevant to assign adjuvant systemic treatment in early breast cancer?

M. Gennaro, A.R. Conti, C. Ferraris, P. Lepera, M. Greco

Journal:

Year:

2003

Language:

english

File:

PDF, 196 KB

english, 2003

71

Prognostic relevance of mitotic activity in patients with node negative breast cancer

L. Medri, A. Volpi, O. Nanni, A.M. Vecci, A. Mangia, F. Padovani, D. Giunchi-Casadei, D. Amadori, A. Paradiso, R. Silvestrini

Journal:

Year:

2003

Language:

english

File:

PDF, 196 KB

english, 2003

72

Laterality of pleural metastases in breast cancer

S. Margolin, T. Fornander

Journal:

Year:

2003

Language:

english

File:

PDF, 196 KB

english, 2003

73

Expression of epidermal growth factor receptor 1 (EGFR1) is correlated with over-expression of c-erbB-2, and higher expression of the angiogenic factors basic fibroblast growth factor (BFGF) and vascular endothelial growth factor (VEGF), but do not add prognostic information in primary breast cancer

B.K. Linderholm, B. Lindh, B. Tavelin, M. Erlanson, L. Beckman, K. Grankvist, R. Henriksson

Journal:

Year:

2003

Language:

english

File:

PDF, 196 KB

english, 2003

74

Progesterone receptor expression defines subsets of tumors at high risk for nodal invasion in early (pT1) breast cancer

J. Schneider, A.R. Lucas, J. Sanchez, A. Tejerina, M. Pollan

Journal:

Year:

2003

Language:

english

File:

PDF, 192 KB

english, 2003

75

Vascular endothelial growth factor as a prognostic indicator in breast carcinoma

N. Dedic Plavetic, J. Jakic Razumovic, D. Vrbanec

Journal:

Year:

2003

Language:

english

File:

PDF, 192 KB

english, 2003

76

Very high steroid receptor content in postmenopausal breast cancer patient: The unfavorable predictive factor?

Z. Neskovic-Konstantinovic, S. Susnjar, S. Vasovic, D. Nikolic-Vukosavljevic

Journal:

Year:

2003

Language:

english

File:

PDF, 192 KB

english, 2003

77

Molecular profiling of core biopsies of breast cancer by quantitative rt-PCR (Qrt-PCR)

Vincent Vuaroqueaux, Martin Labuhn, Willy Küng, Edward Wight, Rosanna Zanetti, Serenella Eppenberger-Castori, Gregor Fürstenberger, Urs Eppenberger

Journal:

Year:

2003

Language:

english

File:

PDF, 382 KB

english, 2003

78

Pathological profile in young women with breast cancer

H. Hillhouse, Z. Saad, B. Magee, S. Bashir, J. Jeffree

Journal:

Year:

2003

Language:

english

File:

PDF, 194 KB

english, 2003

79

Expression of Ki-67 in breast carcinomas and its relationship with others prognostic variables

M. Frangou-Plemenou, P. Kairi-Vassilatou, K. Dimopoulou, D. Karandrea, A. Kondi-Pafiti

Journal:

Year:

2003

Language:

english

File:

PDF, 194 KB

english, 2003

80

Mutations in the mitochondrial DNA (mtDNA) in breast cancer tissue

L. Szatkowska, J. Rzymowska, A. Brzozowska, M. Mazurkiewicz

Journal:

Year:

2003

Language:

english

File:

PDF, 194 KB

english, 2003

81

Angiogenesis in ductal breast carcinoma and its correlation with the prognostic parameters

M. Frangou-Plemenou, A. Metafa-Prahalia, D. Karandrea, A. Kondi-Pafiti

Journal:

Year:

2003

Language:

english

File:

PDF, 194 KB

english, 2003

82

Analysis of survival and disease free survival of four hundred and fifty-two lobular carcinomas

V. Gaki, D. Baltas, N. Bredakis, J. Louis, D. Chrisanthakis, G. Vourli, K. Pavlaki, A. Keramopoullous

Journal:

Year:

2003

Language:

english

File:

PDF, 387 KB

english, 2003

83

Assessment of her2-neu status in core needle biopsy of 215 patients with primary breast cancer

S. Taucher, M. Rudas, M. Gnant, D. Kandioler, P. Dubsky, Th. Bachleitner, S. Roka, M. Mittlboeck, G. Steger, R. Jakesz

Journal:

Year:

2003

Language:

english

File:

PDF, 197 KB

english, 2003

84

Lymphographic map of the breast

D. Pavlista, O. Eliska, M. Duskova

Journal:

Year:

2003

Language:

english

File:

PDF, 197 KB

english, 2003

85

Detection of micrometastases in peripheral blood by immunomagnetic cell separation in patients with breast cancer

A. Lebrecht, K. Bluemke, H. Taubert, U. Bilkenroth, H.J. Holzhausen, E. Ulbrich, H. Koelbl

Journal:

Year:

2003

Language:

english

File:

PDF, 197 KB

english, 2003

86

Characteristics of brain metastases from node negative breast cancer

M. Saito, M. Yoshimoto, F. Akiyama, G. Sakamoto, F. Kasumi, M. Kaminishi

Journal:

Year:

2003

Language:

english

File:

PDF, 383 KB

english, 2003

87

Unilateral multicentric breast cancer

J. Fajdić, D. Hodžić, I. Bagarić

Journal:

Year:

2003

Language:

english

File:

PDF, 190 KB

english, 2003

88

Clinical features of male breast cancer

A. Mudenas, A. Jackevicius, S. Bruzas, A. Luksyte

Journal:

Year:

2003

Language:

english

File:

PDF, 190 KB

english, 2003

89

Features of current and the prognostic factors of the male breast cancer (MBC)

E.S. Hoto, V.P. Letyagin

Journal:

Year:

2003

Language:

english

File:

PDF, 190 KB

english, 2003

90

Estrogen receptor-alpha, bcl-2 and c-myc gene expression in fibroadenomas and adjacent normal breast: Association with the phase of menstrual cycle, use of oral contraception and nulliparity

R. Cericatto, A. Pozzobon, J. Biazús, C. Menke, I. Silva, P. Spritzer

Journal:

Year:

2003

Language:

english

File:

PDF, 392 KB

english, 2003

91

Correlation between bcl-2 and c-erb-B2 in serum at breast cancer

R. Iosifidou, G. Galaktidou, F. Patakiouta, A. Bousoulegas

Journal:

Year:

2003

Language:

english

File:

PDF, 207 KB

english, 2003

92

A mechanistic study of tamoxifen induced apoptosis in the MCF-7 and MDA-MB468 breast cancer cell lines

S. Salami, F. Karami-Tehrani

Journal:

Year:

2003

Language:

english

File:

PDF, 207 KB

english, 2003

93

Different EGF-R content in primary breast carcinomas, metastatic lymph nodes and invaded skin: The tissue characteristics or the breast carcinoma biological property?

Z. Neskovic-Konstantionovic, D. Nikolic-Vukosavljevic, K. Kanjer, D. Jovanovic, D. Vukotic

Journal:

Year:

2003

Language:

english

File:

PDF, 207 KB

english, 2003

94

Nuclear accumulation of p53 in primary breast cancer: The correlation with free and total prolactin receptors

F. Karami-Tehrani, S. Salami, M. Sirati Sabet

Journal:

Year:

2003

Language:

english

File:

PDF, 207 KB

english, 2003

95

The influence of GABA on asymptotic survival time and categories of failures in patients treated for breast carcinoma

A. Brzozowska, M. Mazurkiewicz, L. Szatkowska

Journal:

Year:

2003

Language:

english

File:

PDF, 195 KB

english, 2003

96

Serum levels of IGF-1 and IGFBP-3 during adjuvant chemotherapy for primary breast cancer

G. Fürstenberger, R. Morant, B. Bolliger, H.J. Senn

Journal:

Year:

2003

Language:

english

File:

PDF, 195 KB

english, 2003

97

Effects of adjuvant therapies in breast cancer on tumor specific memory T cells (MTC) derived from bone marrow (bm)

F. Schuetz, K. Ehlert, P. Beckhove, I.J. Diel, E. Solomayer, V. Schirrmacher, G. Bastert, H.J. Strittmatter

Journal:

Year:

2003

Language:

english

File:

PDF, 195 KB

english, 2003

98

Clinical significance of thymidine phosphorylase in adjuvant therapy for breast cancer: Comparison of 5−deoxy-5-fluorourdine and cytophosphamide with CMF

R. Nishimura, K. Nagao, H. Miyayama

Journal:

Year:

2003

Language:

english

File:

PDF, 195 KB

english, 2003

99

Increased aromatase inhibitor potency: Correlation with clinical efficacy?

Journal:

Year:

2003

Language:

english

File:

PDF, 324 KB

english, 2003

100

Simultaneous determination of steroid hormone receptors and estrogen-regulated proteins pS2 and cathepsin D in breast carcinomas

D. Nikolic-Vukosavljevic, G. Grujic-Adanja, M. Markicevic

Journal:

Year:

2003

Language:

english

File:

PDF, 134 KB

english, 2003

101

Effects of exemestane on lipid metabolism compared with anastrozole in ovariectomized rats

Y. Hozumi, Y. Hakamata, K. Endo, H. Nagai

Journal:

Year:

2003

Language:

english

File:

PDF, 134 KB

english, 2003

102

Intraoperative electron boost radiotherapy (IORT) versus postoperative external electron beam boost radiation in breast cancer patients — A sequential intervention study on local recurrence rates

R. Reitsamer, F. Peintinger, F. Sedlmayer, M. Kopp, C. Menzel

Journal:

Year:

2003

Language:

english

File:

PDF, 192 KB

english, 2003

103

Partial breast irradiation with 192-iridium implants after breast conserving surgery: perioperative morbidity, toxicity and cosmetic results

O. Ott, V. Strnad, R. Poetter, J. Hammer, A. Resch, G. Kovacs, M.W. Beckmann, R. Sauer

Journal:

Year:

2003

Language:

english

File:

PDF, 192 KB

english, 2003

104

Short fractionation schedule in breast irradiation: Preliminary results

A. Kuten, L. Leitzin, E. Rosenblatt, A. Tamir, M. Schnaidman

Journal:

Year:

2003

Language:

english

File:

PDF, 192 KB

english, 2003

105

Long-term cardiac side effects of post operative irradiation studied with myocardial scintigraphy

U. Blom-Goldman, T. Fornander

Journal:

Year:

2003

Language:

english

File:

PDF, 192 KB

english, 2003

106

Radioguided occult lesions localisation (ROLL) of the nonpalpable breast lesions using reduced dose (1,8 MBq) of radioactivity

J. Zgajnar, N. Besic, M. Hocevar, B. Vidergar, K. Hertl, S. Frkovic-Grazio

Journal:

Year:

2003

Language:

english

File:

PDF, 186 KB

english, 2003

107

Breast conservation: A two year experience with HDR boost — VN Cancer Centre, Coimbatore, India

G. Govindarajulu, V. Nagarajan, N.R. Tulasi, M. Nagarajan, J. Subash, P. Gnanaprakasam

Journal:

Year:

2003

Language:

english

File:

PDF, 186 KB

english, 2003

108

Novel surgical sampling using mri for assessment of nodal status in breast cancer with failure to identify a sentinel lymph node

T. Suszuma, T. Sakurai, G. Yoshimura, T. Umemura, Y. Shimizu, Q. Yang, K. Kakudo

Journal:

Year:

2003

Language:

english

File:

PDF, 186 KB

english, 2003

109

Sentinel lymph node biopsy after neoadjuvant therapy in breast cancer

J. Tio, M. Buehner, H. Volkholz, A.H. Tulusan

Journal:

Year:

2003

Language:

english

File:

PDF, 186 KB

english, 2003

110

Breast conserving therapy for the elderly

J. Tio, M. Buehner, H. Volkholz, A.H. Tulusan

Journal:

Year:

2003

Language:

english

File:

PDF, 374 KB

english, 2003

111

Surgical treatment of the male breast cancer: What amount is optimal?

E.S. Hotko, V.P. Letyagin

Journal:

Year:

2003

Language:

english

File:

PDF, 192 KB

english, 2003

112

Advanced age, risk factor for undertreatment of breast cancer in every day practice

S. Vasovic, Z. Tomasevic, Lj. Stamatovic, S. Jelic

Journal:

Year:

2003

Language:

english

File:

PDF, 192 KB

english, 2003

113

10-year follow-up update of French adjuvant study group 05 trial: FEC 100 regimen remains superior to FEC 50 in adjuvant chemotherapy of poor prognosis, node-positive, early breast cancer patients

V. Servent, J. Bonneterre, H. Roché, P. Kerbrat, A. Brémond, P. Fumoleau, M. Namer, M.J. Goudier, P. Fargeot, I. Chapelle-Marcillac

Journal:

Year:

2003

Language:

english

File:

PDF, 192 KB

english, 2003

114

Adjuvant polychemotherapy vs control for node-negative, rapidly proliferating breast cancer: Combined analysis of two phase III trials

A. Paradiso, M. De Lena, F. Schittulli, A. Mangia, O. Nanni, A. Volpi, D. Casadei-Giunchi, D. Amadori

Journal:

Year:

2003

Language:

english

File:

PDF, 378 KB

english, 2003

115

The triplet gemcitabine (G), epirubicin (E) and docetaxel (Doc) is feasible, safe and highly active as primary systemic therapy (PST) of patients (pts) with multicentric phase I/II trial

A. Schneeweiss, M. Geberth, K. Krauss, F. Beldermann, U. Wagner, D. von Fournier, R. Hamerla, D. Wallweiner, G. Bastert, J. Huober

Journal:

Year:

2003

Language:

english

File:

PDF, 192 KB

english, 2003

116

Postoperative adjuvant therapy with tamoxifen, tegafur-uracil (UFT) or both in women with node-negative breast cancer: A pooled analysis of six randomized controlled trials (ACETBC 4th trial)

T. Ikeda, J. Uchino, R. Abe, S. Miura, H. Koyama, K. Sugimachi, K. Akazawa, O. Abe

Journal:

Year:

2003

Language:

english

File:

PDF, 192 KB

english, 2003

117

Weekly docetaxel in metastatic beast cancer (MBC) and correlation between serum CA15-3 and HER2-ECD

Journal:

Year:

2003

Language:

english

File:

PDF, 192 KB

english, 2003

118

Phase III study evaluating the role of docetaxel in the adjuvant therapy of breast cancer patients with extensive lymph node involvement (4 nodes+) — ADEBAR study

B. Rack, W. Janni, N. Harbeck, I. Zemzoun, B. Strobl, E. Klanner, J. de Waal, C. Schindlbeck, M. Kiechle, H. Sommer

Journal:

Year:

2003

Language:

english

File:

PDF, 201 KB

english, 2003

119

Primary endpoint analysis of the GEPARDUO study: Comparing dose-dense with sequential adriamycin/docetaxel combination as preoperative chemotherapy (PCHT) in operable breast cancer (T2-3, N0-2, M0)

A. Loehr, G. von Minckwitz, G. Raab, M. Schuette, J.U. Blohmer, J. Hilfrich, B. Gerber, S.B. Costa, A. Caputo, M. Kaufmann

Journal:

Year:

2003

Language:

english

File:

PDF, 201 KB

english, 2003

120

Updated survival analyses from the ZEBRA study: goserelin vs CMF in premenopausal women with node-positive breast cancer

M. Schumacher, R. Blamey, J. Cuzick, J. De Haes, W. Eirmann, I. Fogelman, W. Jonat, M. Kaufmann, M. Namer, W. Sauerbrei

Journal:

Year:

2003

Language:

english

File:

PDF, 201 KB

english, 2003

121

Adjuvant chemotherapy (ADCT) in breast cancer (BC) after 65 years

H. Auvray, P. Chollet, J-P. Ferriere, J. Dauplat, G. Le Bouedec, J.L. Achard, M. De Latour

Journal:

Year:

2003

Language:

english

File:

PDF, 380 KB

english, 2003

122

Neoadjuvant chemotherapy for breast cancer treatment

B. Alonso Alvarez, M. Llanos Muñoz, M.R. Aleman Valls, J. Oramas Rodríguez, L.M. Rodríguez Rodríguez, J. Cruz Jurado, R.D. García Marrero, M.A. Cabrera Suarez, S. Cedres Perez, N. Batista Lopez

Journal:

Year:

2003

Language:

english

File:

PDF, 185 KB

english, 2003

123

The role of neoadjuvant treatment with combination of docetaxel and doxorubicin for breast cancer patients

A. Jagiello-Gruszfeld, E. Filipczuk-Cirsaz, M. Foszczynska-Kloda, K. Drosik, B. Liszka, B. Kaczmarek-Borowska, J. Zaluski, T. Pienkowski, M. Suszko-Kazarnowicz, M. Krzakowski

Journal:

Year:

2003

Language:

english

File:

PDF, 185 KB

english, 2003

124

Predictive and prognostic factors in patients treated by neoadjuvant chemotherapy

S. Amat, P. Chollet, E. Belembaogo, M-A. Mouret-Reynier, G. Le Bouedec, V. Feillel, H. Auvray, H. Cure, F. Penault-Llorca

Journal:

Year:

2003

Language:

english

File:

PDF, 376 KB

english, 2003

125

Increasing the dose intensity of adjuvant chemotherapy may improve the outcome of node-positive breast cancer patients

E. Del Barco, M.I. Ruiz, C.A. Rodriguez, A. Gomez, P. Sanchez, G. Martin, E. Fonseca, G. Garcia, R. Salazar, J.J. Cruz

Journal:

Year:

2003

Language:

english

File:

PDF, 196 KB

english, 2003

126

Fewer endometrial abnormalities with anastrozole than tamoxifen: Endometrial subprotocol results from the ATAC ('Arimidex', Tamoxifen, Alone or in Combination) early breast cancer trial in postmenopausal patients

Journal:

Year:

2003

Language:

english

File:

PDF, 196 KB

english, 2003

127

Anastrazol (A) vs tamoxifen (T) vs combine (A+T) as neoadjuvant endocrine therapy of postmenopausal breast cancer patients

V.F. Semiglazov, V.V. Semiglazov, V.G. Ivanov, E.K. Ziltzova, G.A. Dashyan, A. Kletzel, A.A. Bozhok, K.S. Nurgaziev, E.V. Tzyrlina, L.M. Berstein

Journal:

Year:

2003

Language:

english

File:

PDF, 196 KB

english, 2003

128

Preliminary results of a pilot-trial with trastuzumab + weekly epidoxorubicin/docetaxel in the neoadjuvant treatment of primary, operable breast cancer

G.G. Steger, C. Wenzel, R. Bartsch, M. Rudas, M.F. Gnant, C.C. Zielinski, R. Jakesz

Journal:

Year:

2003

Language:

english

File:

PDF, 413 KB

english, 2003

129

Pharmacokinetics of herceptin administered three-weekly compared to weekly — A simulation based on data from the clinical studies

P. Ghahramani, C. Barton, B. Leyland-Jones

Journal:

Year:

2003

Language:

english

File:

PDF, 221 KB

english, 2003

130

Adjuvant hormonetherapy for slow proliferating node-negative breast cancer patients. Results of the phase III trial of NCl-Bari

A. Paradiso, M. De Lena, M. Sambiasi, A. Mangia, M. Brandi, F. Schittulli

Journal:

Year:

2003

Language:

english

File:

PDF, 221 KB

english, 2003

131

Prospective pilot study of the preoperative use of celecoxcib and FEC for the treatment of locally advanced breast cancer

L. Chow, M. Toi

Journal:

Year:

2003

Language:

english

File:

PDF, 221 KB

english, 2003

132

Stopping tamoxifen after 5 years. What's next?

A. Keramopoullos, V. Gaki, D. Baltas, N. Bredakis, G. Vourli, A. Ghiatas, K. Pavlaki

Journal:

Year:

2003

Language:

english

File:

PDF, 429 KB

english, 2003

133

Primary chemotherapy in breast cancer shows excellent clinical and pathological response with docetaxel and epirubicin

H.R.C. Marana, J.M. Andrade, D.G. Tiezzi, M.F. Taborda, A.H. Machetti, H.H.A. Carrara, F.J.C. Reis, S. Bighetti

Journal:

Year:

2003

Language:

english

File:

PDF, 212 KB

english, 2003

134

Cardiac safety of 3-weekly herceptin monotherapy

J. Baselga, N.-J. Castaneda-Soto, M. Clemens, M. Green, V. Harvey, S. Morales, C. Barton

Journal:

Year:

2003

Language:

english

File:

PDF, 212 KB

english, 2003

135

Undertreatment of anemia in patients with breast cancer (BC): Data from the European Cancer Anaemia Survey (ECAS)

S. Van Belle, P.J. Barrett-Lee

Journal:

Year:

2003

Language:

english

File:

PDF, 432 KB

english, 2003

136

Assessing the quality of life of postmenopausal women randomized into the ATAC (“arimidex”, tamoxifen, alone or in combination) adjuvant breast cancer trial

L. Fallowfield, D. Cella

Journal:

Year:

2003

Language:

english

File:

PDF, 223 KB

english, 2003

137

Does treatment for breast cancer affect cognition? A pilot study using a pragmatic cognitive assessment package

V. Jenkins, L. Fallowfield, V. Shilling, A. Howell, S. Hutton

Journal:

Year:

2003

Language:

english

File:

PDF, 223 KB

english, 2003

138

Intravenous administration of zoledronic acid prevents the bone loss and reduction of mechanical properties induced by aromatase inhibition or surgical ovariectomy in rats

J.A. Gasser, J.R. Green, V. Shen, R. Leininger, A.S. Bhatnagar, D.B. Evans

Journal:

Year:

2003

Language:

english

File:

PDF, 223 KB

english, 2003

139

Zoledronic acid is superior to pamidronate in patients with breast cancer and bone metastases

L. Rosen, R. Coleman, D. Gordon, P. Major, M. Kaminski, J. Apffelstaedt, A. Howell, B.L. Chen, J. Seaman

Journal:

Year:

2003

Language:

english

File:

PDF, 402 KB

english, 2003

140

Zoledronic acid prevents bone mineral density loss in premenopausal women receiving adjuvant treatment for hormone receptor-positive breast cancer: Preliminary results of a randomized, multicenter trial of zoledronic acid in patients receiving anastrozole or tamoxifen in combination with goserelin

H. Hausmaninger

Journal:

Year:

2003

Language:

english

File:

PDF, 184 KB

english, 2003

141

Influence of anemia on local relapse free survival (LRFS) of premenopausal primary breast cancer patients under adjuvant CMF chemotherapy: An analysis of the Austrian Breast Cancer Study Group

P. Sevelda, M. Gnant

Journal:

Year:

2003

Language:

english

File:

PDF, 184 KB

english, 2003

142

Tailored treatment investigations for premenopausal women with endocrine responsive (ER+ and/or PgR+) breast cancer: The open questions

R.D. Gelber, M. Castiglione-Gertsch, A.S. Coates, A. Goldhirsch

Journal:

Year:

2003

Language:

english

File:

PDF, 383 KB

english, 2003

143

Tailored treatment investigations for premenopausal women with endocrine responsive (ER+ and/or PGR+) breast cancer: The SOFT, TEXT, and PERCHE trials

P. Francis, G. Fleming, M.L. Nasi, O. Pagani, E. Perez, B. Walley

Journal:

Year:

2003

Language:

english

File:

PDF, 204 KB

english, 2003

144

PRIME: A randomised trial assessing the role of post-operative breast radiotherapy in older patients

I.K. Kunkler, R.J. Prescott, L.J. Williams, C.C. King, J.M. Dixon, R. Lindley, R. Leonard, J. Cairns, A. Rodger, R. Sainsbury

Journal:

Year:

2003

Language:

english

File:

PDF, 204 KB

english, 2003

145

Phase III randomized adjuvant study of tamoxifen alone versus sequential tamoxifen and anastrozole in hormone-responsive postmenopausal breast cancer patients (National Surgical Adjuvant Study of Breast Cancer [NSAS BC] 03)

Y. Takatsuka, T. Aihara

Journal:

Year:

2003

Language:

english

File:

PDF, 204 KB

english, 2003

146

Cost-effectiveness projections of anastrazole (AN) vs. tamoxifen (T) as initial adjuvant therapy in ER-positive early breast cancer using data from the ATAC trial

Journal:

Year:

2003

Language:

english

File:

PDF, 407 KB

english, 2003

147

How important is dose intensity of adjuvant chemotherapy for early breast cancer? A comparison of physician perception with actual practice

D. Kerr-Cresswell, G. DeBoer, M. Trudeau, F. Charbonneau, G. Yogendran, A. Mehlenbacher, M. Clemons

Journal:

Year:

2003

Language:

english

File:

PDF, 209 KB

english, 2003

148

Long-term follow-up in breast cancer: Is it necessary?

M. Cooper, Z. Saad, B. Magee, J. Jeffree, S. Bashir

Journal:

Year:

2003

Language:

english

File:

PDF, 209 KB

english, 2003

149

WSG/AGO-Mamma phase III trial: First toxicity analysis of a German intergroup study for patients with primary breast cancer and 1–3 positive axillary lymph nodes. Comparison of six cycles FEC or CMF chemotherapy with four cycles EC followed by four cycles of docetaxel

G. Schuett, S. Mohrmann, V. Heilmann, D. Sattler, H.G. Bender, W. Kuhn, U. Nitz

Journal:

Year:

2003

Language:

english

File:

PDF, 209 KB

english, 2003

150

Antimutagenicity of ether and ethyl acetate fractions of acacia nilotica in Ames assay

K. Kamaljit Kaur, S. Saroj Arora, S. Subodh Kumar

Journal:

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

151

Imprint cytology of needle core-biopsy specimens of breast lesion: Is it best of both worlds

A.R. Carmichael, A. Berresford, A. Sami, R. Bhopari

Journal:

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

152

The ATAC (‘Arimidex’, Tamoxifen, Alone or in Combination) trial in postmenopausal women with early breast cancer—Updated efficacy results based on a median follow-up of 47 months

Journal:

Year:

2003

Language:

english

File:

PDF, 172 KB

english, 2003

153

A 7-month (MTH) safety update from the ATAC (‘Arimidex’, Tamoxifen, Alone or in Combination) trial: Anastrozole (A) maintains a beneficial side-effect profile compared with tamoxifen (T)

Journal:

Year:

2003

Language:

english

File:

PDF, 270 KB

english, 2003

154

Progesterone receptor quality and level have a significant prognostic and predictive impact in pre- and postmenopausal patients with hormone-responsive breast cancer: six-year results of ABCSG trials 5 and 6

Journal:

Year:

2003

Language:

english

File:

PDF, 103 KB

english, 2003

155

The prognostic value of HER-2/neu status in premenopausal patients with hormone-responsive breast cancer

Journal:

Year:

2003

Language:

english

File:

PDF, 103 KB

english, 2003

156

Author index

Journal:

Year:

2003

File:

PDF, 346 KB

2003

157

Polyneuroendocrine therapy of advanced breast cancer with LHRH analogue, tamoxifen and the antiprolactinemic drug cabergoline: Phase 2 study

P. Lissoni, A. Ardizzoia, G. Cerea, M. Acquati, M. Simonelli, M. Vaghi, G. Tancini, G. Gardani

Journal:

Year:

2003

Language:

english

File:

PDF, 212 KB

english, 2003

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Tor version

Z-Library

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски